Design, Synthesis, and Bioactivities Screening of Diaryl Ketone
Compared with the antifungal activities of compounds III1, III2, and
Muller G., editors. Chemogenomics in Drug Discovery: A Medic-
inal Chemistry Perspective. Weinheim: Wiley-VCH; p. 377–403.
4. Wetzel S., Schufffenhauer A., Roggo S., Ertl P., Waldmann H.
(2007) Cheminformatic analysis of natural products and their
chemical space. Chimia;61:355–360.
5. Yang G., Liao Z., Xu Z., Zhang H., Chen D. (2005) Antimitotic
and antifungal C-3 ⁄ C-3¢'-biflavanones from Stellera chamaej-
asme. Chem Pharm Bull;53:776–779.
6. Barun O., Sommer S., Waldmann H. (2004) Asymmetric solid-
phase synthesis of 6,6-spiroketals. Angew Chem Int Ed;43:3195–
3199.
7. Brohm D., Metzger S., Bhargava A., Muller O., Lieb F., Wald-
mann H. (2002) Natural products are biologically validated start-
ing points in structural space for compound library development:
solid-phase synthesis of dysidiolide-derived phosphatase inhibi-
tors. Angew Chem Int Ed;41:307–311.
III3, the activities of compounds III4–15 were lower. This also
confirmed for us that one compound with substituent groups –F, –
OCH3, and –Cl on the phenyl ring possessed higher antifungal activ-
ities than the other compounds with the other groups, such as –
NO2, –Br, and –Ph.
As shown in Table 4, in comparison with compounds III4–15, com-
pounds III1–3 showed strong activities against a much wider spec-
trum of fungi. In this study, their abilities against fungi were further
examined. As shown in Table 5, compound III2 and compound III3
showed strong activities against R. solani (IC50 = 1.20 mg ⁄ L for III2
and IC50 = 4.02 mg ⁄ L for III3). In comparison with the commercial
agriculture fungicide carbendazim (IC50 = 4.36 mg ⁄ L), these two
compounds show strong potential as a commercial fungicide.
8. Burke M.D., Schreiber S.L. (2004) A planning strategy for diver-
sity-oriented synthesis. Angew Chem Int Ed;43:46–58.
9. Garcia A.B., Lessmann T., Umarye J.D., Mamane V., Sommer S.,
Waldmann H. (2006) Stereocomplementary synthesis of a natural
product-derived compound collection on a solid phase. Chem
Commun;37:3868–3870.
Conclusion
In conclusion, we have synthesized three series of compounds with
a diaryl ketone moiety as pharmacophores. Preliminary bioassays
and biochemical analyses showed that compounds I1–46, II1–14
,
and III1–15 possessed weak insecticidal activities and AChE inhibi-
tory activities. However, we found that compound III with a furan
ring had strong antifungal activities. Among the examined com-
pounds, the IC50 of compound (E )-1-(2,4-dichlorophenyl)-3-
(furan-2-yl)prop-2-en-1-one (III2) was 1.20 mg ⁄ L against
R. solani suggesting its strong potential as a novel antifungal drug.
To our knowledge, this was the first comprehensive report about
antifungal drug screenings based on natural products from S. cha-
maejasme L. Further structural modifications and antifungal activi-
ties optimization on these analogs will be conducted.
10. Lessmann T., Leuenberger M.G., Menninger S., Lopez-Canet M.,
Muller O., Hummer S., Bormann J., Korn K., Fava E., Zerial M.,
Mayer T.U., Waldmann H. (2007) Natural product-derived modu-
lators of cell cycle progression and viral entry by enantioselec-
tive oxa Diels-Alder reactions on the solid phase. Chem
Biol;14:443–451.
11. Mamane V., Garcia A.B., Umarye J.D., Lessmann T., Sommer S.,
Waldmann H. (2007) Stereoselective alkylation of aldehydes on
solid support and its application in biology-oriented synthesis
(BIOS). Tetrahedron;63:5754–5767.
12. Meseguer B., Alonso-Diaz D., Griebenow N., Herget T.,
Waldmann H. (1999) Natural product synthesis on polymeric
supports-synthesis and biological evaluation of an indolactam
library. Angew Chem Int Ed;38:2902–2906.
Acknowledgments
13. Noren-Muller A., Reis-Correa I. Jr, Prinz H., Rosenbaum C., Saxe-
na K., Schwalbe H.J., Vestweber D., Cagna G., Schunk S., Sch-
warz O., Schiewe H., Waldmann H. (2006) Discovery of protein
phosphatase inhibitor classes by biology-oriented synthesis. Proc
Natl Acad Sci USA;103:10606–10611.
This study was supported by the Hi-Tech Research and Develop-
ment of China (No. 2009AA032903), the National Natural Science
Foundation of China (Grant No. 30871657, 20972106), and the Ph.D.
Programs Foundation of Ministry of Education of China (Grant No.
20090181110088).
14. Sanz M.A., Voigt T., Waldmann H. (2006) Enantioselective cataly-
sis on the solid phase: synthesis of natural product-derived tetr-
ahydropyrans employing the enantioselective Oxa-Diels-Alder
reaction. Adv Synth Catal;348:1511–1515.
References
15. Sauerbrei B., Jungmann V., Waldmann H. (1998) An enzyme-
labile linker group for organic syntheses on solid supports .
Angew Chem Int Ed;37:1143–1146.
16. Sommer S., Waldmann H. (2005) Solid phase synthesis of a spir-
o[5.5]ketal library. Chem Commun;45:5684–5686.
17. Stahl P., Kissau L., Mazitschek R., Giannis A., Waldmann H.
(2002) Natural product derived receptor tyrosine kinase
inhibitors: identification of IGF1R, Tie-2, and VEGFR-3 inhibitors.
Angew Chem Int Ed;41:1174–1178.
1. Breinbauer R., Vetter I.R., Waldmann H. (2002) From protein
domains to drug candidates – Natural products as guiding prin-
ciples in the design and synthesis of compound libraries. Angew
Chem Int Ed;41:2879–2890.
2. Koch M.A., Schuffenhauer A., Scheck M., Wetzel S., Casaulta
M., Odermatt A., Ertl P., Waldmann H. (2005) Charting biologi-
cally relevant chemical space: a structural classification of
natural products (SCONP). Proc Natl Acad Sci USA;102:17272–
17277.
18. Umarye J.D., Lessmann T., Garcia A.B., Mamane V., Sommer S.,
Waldmann H. (2007) Biology-oriented synthesis of stereochemi-
cally diverse natural-product-derived compound collections by
3. Koch M.A., Waldmann H. (2004) Natural Product-Derived
Compound Libraries and Protein Structure Similarity As Guiding
Principles for the Discovery of Drug Candidates. In: Kubinyi H.,
Chem Biol Drug Des 2011; 78: 94–100
99